Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1984 Dec;83(4):943–949. doi: 10.1111/j.1476-5381.1984.tb16535.x

Energy conservation by nisoldipine in ischaemic heart.

J W De Jong, T Huizer, J G Tijssen
PMCID: PMC1986981  PMID: 6518345

Abstract

We studied the effect of the calcium entry blocker nisoldipine on ATP catabolism in the rat heart, perfused according to Langendorff. Even 1 nM nisoldipine induced vasodilatation; concentrations of 30 nM and higher caused significant negative inotropy. The drug had a very strong affinity for silicon rubber tubing. Myocardial ischaemia was induced by lowering the perfusion pressure, which reduced flow without nisoldipine by 85%. The efflux of purine nucleosides and oxypurines rose 14 fold. Nisoldipine reduced this efflux of ATP catabolites dose-dependently. The highest concentration, 300 nM, suppressed ischaemic purine production completely. The action of the drug was antagonized by an increase in Ca2+-concentration in the perfusion fluid. We also showed the protective effect of nisoldipine on adenine nucleotides in freeze-clamped hearts. A concentration of 20 nM partially prevented the reduction of ATP and adenylate energy charge due to ischaemia. We conclude that relatively low doses of nisoldipine effectively prevent ATP breakdown in ischaemic rat heart.

Full text

PDF
948

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Daly M. J., Perry S., Nayler W. G. Calcium antagonists and calmodulin: effect of verapamil, nifedipine and diltiazem. Eur J Pharmacol. 1983 May 20;90(1):103–108. doi: 10.1016/0014-2999(83)90219-4. [DOI] [PubMed] [Google Scholar]
  2. De Jong J. W., Harmsen E., De Tombe P. P., Keijzer E. Nifedipine reduces adenine nucleotide breakdown in ischemic rat heart. Eur J Pharmacol. 1982 Jun 16;81(1):89–96. doi: 10.1016/0014-2999(82)90604-5. [DOI] [PubMed] [Google Scholar]
  3. Drake-Holland A. J., Noble M. I. Myocardial protection by calcium antagonist drugs. Eur Heart J. 1983 Nov;4(11):823–825. doi: 10.1093/oxfordjournals.eurheartj.a061405. [DOI] [PubMed] [Google Scholar]
  4. Harmsen E., de Jong J. W., Serruys P. W. Hypoxanthine production by ischemic heart demonstrated by high pressure liquid chromatography of blood purine nucleosides and oxypurines. Clin Chim Acta. 1981;115(1):73–84. doi: 10.1016/0009-8981(81)90108-x. [DOI] [PubMed] [Google Scholar]
  5. Harmsen E., de Tombe P. P., de Jong J. W. Simultaneous determination of myocardial adenine nucleotides and creatine phosphate by high-performance liquid chromatography. J Chromatogr. 1982 Jun 11;230(1):131–136. doi: 10.1016/s0378-4347(00)81439-5. [DOI] [PubMed] [Google Scholar]
  6. Kazda S., Garthoff B., Meyer H., Schlossmann K., Stoepel K., Towart R., Vater W., Wehinger E. Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay k 5552). Arzneimittelforschung. 1980;30(12):2144–2162. [PubMed] [Google Scholar]
  7. Nayler W. G. Protection of the myocardium against postischemic reperfusion damage. The combined effect of hypothermia and nifedipine. J Thorac Cardiovasc Surg. 1982 Dec;84(6):897–905. [PubMed] [Google Scholar]
  8. Norman J. A., Ansell J., Phillips M. A. Dihydropyridine Ca2+ entry blockers selectively inhibit peak I cAMP phosphodiesterase. Eur J Pharmacol. 1983 Sep 16;93(1-2):107–112. doi: 10.1016/0014-2999(83)90036-5. [DOI] [PubMed] [Google Scholar]
  9. Pang D. C., Sperelakis N. Uptake of [3H]nitrendipine into cardiac and smooth muscles. Biochem Pharmacol. 1983 May 15;32(10):1660–1663. doi: 10.1016/0006-2952(83)90347-7. [DOI] [PubMed] [Google Scholar]
  10. Saida K., van Breemen C. Inhibiting effect of diltiazem on intracellular Ca2+ release in vascular smooth muscle. Blood Vessels. 1983;20(2):105–108. doi: 10.1159/000158464. [DOI] [PubMed] [Google Scholar]
  11. Schoutsen B., De Jong J. W., Harmsen E., De Tombe P. P., Achterberg P. W. Myocardial xanthine oxidase/dehydrogenase. Biochim Biophys Acta. 1983 Jul 14;762(4):519–524. doi: 10.1016/0167-4889(83)90055-1. [DOI] [PubMed] [Google Scholar]
  12. Stam H., De Jong J. W. Sephadex-induced reduction of coronary flow in the isolated rat heart: a model for ischemic heart disease. J Mol Cell Cardiol. 1977 Aug;9(8):633–650. doi: 10.1016/s0022-2828(77)80359-3. [DOI] [PubMed] [Google Scholar]
  13. Takahashi K., Kako K. J. The effect of a calcium channel antagonist, Nisoldipine, on the ischemia-induced change of canine sarcolemmal membrane. Basic Res Cardiol. 1983 May-Jun;78(3):326–337. doi: 10.1007/BF01907441. [DOI] [PubMed] [Google Scholar]
  14. Vogt A., Neuhaus K. L., Kreuzer H. Hemodynamic effects of the new vasodilator drug Bay k 5552 in man. Arzneimittelforschung. 1980;30(12):2162–2164. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES